Advanced prostate cancer: What's new in hormonal manipulation?

S. F. Brewster*, D. A. Gillatt

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)


Prostate cancer is the second most common cause of male cancer deaths in the UK. It is one of the few hormone-sensitive cancers and androgen ablation produces subjective and objective tumour regression in 70-80% of patients for a variable period. Orchidectomy remains the gold standard for treatment although there is an increasing number of equally effective medical alternatives.

Original languageEnglish
Pages (from-to)710-715
Number of pages6
JournalBritish Journal of Hospital Medicine
Issue number10
Publication statusPublished - 19 May 1993
Externally publishedYes


Dive into the research topics of 'Advanced prostate cancer: What's new in hormonal manipulation?'. Together they form a unique fingerprint.

Cite this